ArticleTranslational vision science & technology2026
Characterization of a LED-Based Non-Mydriatic Hyperspectral Retinal Camera.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To present a non-mydriatic hyperspectral retinal camera based on spectral scanning, developed to achieve a practical balance among imaging performance, acquisition speed, and system simplicity for advanced retinal diagnostics. Methods: The system integrates LED-based broadband illumination, linear variable filters, custom optics, a monochrome sensor, and a motorized three-dimensional stage to capture high-resolution hyperspectral data across 29 wavebands from 450 to 850 nm. Optical performance was evaluated using standard metrics including spectral resolution, irradiance, uniformity, resolving power, field of view, and chromatic focal compensation. Imaging was performed on model eyes and human subjects to assess spectral signature capture and repeatability. Results: The system achieved a 40° field of view and a spectral resolution ranging from 20 to 80 nm. Chromatic focal correction and illumination uniformity were maintained across the spectral range. In vivo imaging demonstrated the ability to capture distinct spectral signatures of anatomical structures and ocular pathologies. Test-retest assessments showed high repeatability, with spectral variation below 5%. The device operated under non-mydriatic conditions with acquisition times of approximately 300 ms. Conclusions: The prototype demonstrates reliable and repeatable hyperspectral imaging of the retina in a compact and semi-automated form factor. The system offers a foundation for further optimization, including improved spectral precision, artifact reduction, and increased field of view. Translational Relevance: This technology enables non-invasive, high-content retinal imaging suitable for integration into clinical workflows.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.